updated 2/8/2011 2:46:03 AM ET 2011-02-08T07:46:03

COPENHAGEN, Denmark, Feb. 8, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ) today announced that data from its diagnostic program on early detection of colorectal cancer in plasma has been selected for oral presentation at the 102nd Annual American Association for Cancer Research (AACR) Meeting to be held 2-6 April in Orlando, Florida.

The presentation is scheduled to be held on Monday, 4 April 2011, 3:00 PM - 5:00 PM (EST). The title of the presentation is "Discovery of a miRNA-based RT qPCR signature able to detect early stage colorectal cancer in blood plasma."

"The selection for presentation at the AACR is a great acknowledgement of the robust diagnostic PCR platform Exiqon has built, and the ability to use miRNA present in blood-derived serum or plasma as biomarkers. We have completed our discovery studies in 400 patients and controls, and we have access to 5,000 patients for our validation study which we expect to be completed by the end of the year," said Lars Kongsbak, president and CEO.

Exiqon will announce data from the study on Monday, 4 April 2011 at the time of the presentation.

For more information, visit the 2011 AACR Annual Meeting home page at: http://www.aacr.org/page24070.aspx

Additional information:

Lars Kongsbak, President and CEO, tel. +45 4566 0888 (cell: +45 4090 2101)

Hans Henrik Chrois Christensen, CFO, tel. +45 4566 0888 (cell: +45 4090 2131)

See the full release in the attached PDF or at www.exiqon.com/investor/portal

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com